Literature DB >> 2492165

Lithium-induced nephrotic syndrome.

I K Wood1, D X Parmelee, J W Foreman.   

Abstract

The nephrotic syndrome is a rare, idiosyncratic adverse renal effect of lithium that can occur with therapeutic plasma lithium levels. The syndrome is usually reversed by discontinuation of lithium treatment but may require corticosteroids. Renal biopsies reveal fusion of the foot processes of renal epithelial cells, referred to as "minimal change disease." No particular variable identifies individuals at risk for developing the nephrotic syndrome while taking lithium. The authors review the eight published cases in the English-language literature and present the case of an adolescent who developed lithium-induced nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492165     DOI: 10.1176/ajp.146.1.84

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

Review 1.  Drug-induced glomerular disease: direct cellular injury.

Authors:  Glen S Markowitz; Andrew S Bomback; Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-10       Impact factor: 8.237

2.  Lithium-induced membranous glomerulonephropathy in a pediatric patient.

Authors:  Gunjeet K Kala; Muniza Mogri; Edit Weber-Shrikant; James E Springate
Journal:  Pediatr Nephrol       Date:  2009-07-07       Impact factor: 3.714

3.  Special considerations in the treatment of patients with bipolar disorder and medical co-morbidities.

Authors:  Kimberly D McLaren; Lauren B Marangell
Journal:  Ann Gen Hosp Psychiatry       Date:  2004-04-22

4.  Lithium-Induced Minimal Change Disease and Acute Kidney Injury.

Authors:  Parul Tandon; Natalie Wong; Jeffrey S Zaltzman
Journal:  N Am J Med Sci       Date:  2015-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.